Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abatacept For The Treatment Of Primary Biliary Cirrhosis With An Incomplete Biochemical Response To Ursodeoxycholic Acid

NCT02078882 is registered in ClinicalTrials.gov with Christopher Bowlus, MD as lead sponsor.

NCT NCT02078882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02078882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abatacept For The Treatment Of Primary Biliary Cirrhosis With An Incomplete Biochemical Response To Ursodeoxycholic Acid
Lead sponsor
Christopher Bowlus, MD
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2014
Completion date
October 31, 2018
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cirrhosis